COLO B Coloplast A/S Class B

Coloplast A/S - Allocation of Share Options

Coloplast A/S - Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transactions concern allocation of share options.

For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2019. The policy is available on the Group website at this address:

1Details of the person discharging managerial responsibilities/person closely associated
a)NameKristian Villumsen
2Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0054,102
d)Aggregated information 
-  Aggregated volume54,102 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue



1Details of the person discharging managerial responsibilities/person closely associated
a)NameAnders Lonning-Skovgaard
2Reason for the notification
a)Position/statusExecutive Vice President, CFO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0027,473
d)Aggregated information 
-  Aggregated volume27,473 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue



1Details of the person discharging managerial responsibilities/person closely associated
a)NamePaul Marcun
2Reason for the notification
a)Position/statusExecutive Vice President, Chronic Care
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0030,407
d)Aggregated information 
-  Aggregated volume30,407 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue



1Details of the person discharging managerial responsibilities/person closely associated
a)NameAllan Rasmussen
2Reason for the notification
a)Position/statusExecutive Vice President, Global Operations
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0025,500
d)Aggregated information 
-  Aggregated volume25,500 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue

  

1Details of the person discharging managerial responsibilities/person closely associated
a)NameLars Rasmussen
2Reason for the notification
a)Position/statusChairman of the Board of Directors
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0014,904
d)Aggregated information 
-  Aggregated volume14,904 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: .

Attachment

EN
20/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast annoncerer ændringer i ledelsesteamet

Coloplast annoncerer ændringer i ledelsesteamet Coloplast offentliggør i dag ændringer til ledelsesteamet (ELT). Ændringerne omhandler Coloplasts urologiforretning og virksomhedens globale funktion for People & Culture. Leder af People & Culture, Dorthe Rønnau, har besluttet at forlade Coloplast for at starte et nyt kapitel i sin karriere. Dorthe Rønnau har haft forskellige roller på tværs af Coloplast-koncernen i næsten tre årtier. ”Coloplast har haft stor glæde af Dorthes værdier, integritet og stærke lederevner i hendes roller i Global Operations, Atos og People & Culture, og den øvers...

 PRESS RELEASE

Coloplast announces changes to Executive Leadership Team

Coloplast announces changes to Executive Leadership Team Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate to the company’s Interventional Urology business as well as the global People & Culture function. Executive Vice President of People & Culture, Dorthe Rønnau, has decided to leave Coloplast to pursue the next chapter in her career. She has spent close to three decades in different roles across the Coloplast Group. “Dorthe’s values, integrity and strong leadership skills have benefitted the company across her roles in Global Op...

 PRESS RELEASE

Coloplast A/S - Beslutninger på den ordinære Generalforsamling 2025

Coloplast A/S - Beslutninger på den ordinære Generalforsamling 2025 I dag, den 4. december 2025, afholdt Coloplast A/S sin ordinære generalforsamling, hvor følgende beslutninger blev vedtaget: Årsrapporten for regnskabsåret 2024/25 blev godkendt.Forslag om udbetaling af udbytte for året på 18,00 kr. pr. aktie à nominelt 1 kr. blev godkendt. I tillæg til de 5,00 kr. pr. aktie à nominelt 1 kr., der blev udbetalt i forbindelse med Coloplast A/S’ halvårsresultat, bliver det samlede udbytte for regnskabsåret 2024/25 således 23,00 kr. pr. aktie à nominelt 1 kr.Vederlagsrapporten for regnskabsåre...

 PRESS RELEASE

Coloplast A/S - Decisions at the Annual General Meeting 2025

Coloplast A/S - Decisions at the Annual General Meeting 2025 Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2024/25 was approved.Distribution of year-end dividend of DKK 18.00 per share of nominally DKK 1 was approved. In addition to the interim dividend of DKK 5.00 per share of nominally DKK 1 paid out in connection with Coloplast A/S’ half- year result, this brings the total dividend paid for the financial year 2024/25 to DKK 23.00 per share of nominally DKK 1.The remuneratio...

 PRESS RELEASE

Coloplast A/S - Notice of Annual General Meeting 2025

Coloplast A/S - Notice of Annual General Meeting 2025 Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium), Humlebæk, Denmark. The notice of the Annual General Meeting is enclosed.   For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. Kristine Husted MunkSr. Director, Investor RelationsTel. / Email: Simone Dyrby HelvindSr. Manager, Inve...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch